Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
SUBBIAH, VIVEK
One or more keywords matched the following items that are connected to SUBBIAH, VIVEK
Item TypeName
Concept Oncogene Proteins, Fusion
Academic Article Ewing's sarcoma: standard and experimental treatment options.
Academic Article Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein.
Academic Article Morphoproteomic profiling of the mammalian target of rapamycin (mTOR) signaling pathway in desmoplastic small round cell tumor (EWS/WT1), Ewing's sarcoma (EWS/FLI1) and Wilms' tumor(WT1).
Academic Article Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases.
Academic Article Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion.
Academic Article Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology.
Academic Article Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations.
Academic Article Patient-driven discovery and post-clinical validation of NTRK3 fusion as an acquired resistance mechanism to selpercatinib in RET fusion-positive lung cancer.
Academic Article Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant Cancers.
Search Criteria
  • Oncogene Proteins Fusion